Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China flag China · Delayed Price · Currency is CNY
26.84
+1.22 (4.76%)
At close: Mar 6, 2026

SHA:688443 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-797.27-801.32-576.37-322.13
Depreciation & Amortization
66.6559.1749.9438.5
Other Amortization
7.944.613.695.56
Loss (Gain) From Sale of Assets
0--0-
Asset Writedown & Restructuring Costs
0.54000.7
Loss (Gain) From Sale of Investments
-2.73-1.94-7.86-4.13
Provision & Write-off of Bad Debts
0.63---0.03
Other Operating Activities
29.5134.0133.9932.15
Change in Accounts Receivable
-40.889.88-7.71-105.1
Change in Inventory
4.691.85-22.67-17.81
Change in Accounts Payable
1.7351.155.87131.8
Change in Other Net Operating Assets
153.76265.07293.472.68
Operating Cash Flow
-575.44-377.58-177.64-237.82
Capital Expenditures
-45.32-90.98-146.21-112.7
Sale of Property, Plant & Equipment
0.04--0
Investment in Securities
-382.28211.6194.2-409.24
Other Investing Activities
0.14-3.41.12
Investing Cash Flow
-427.42120.6251.4-520.82
Short-Term Debt Issued
---73.32
Long-Term Debt Issued
212.91109.63208.35186.79
Total Debt Issued
212.91109.63208.35260.11
Short-Term Debt Repaid
----499.15
Long-Term Debt Repaid
-23.39-257.25-14.88-9.07
Total Debt Repaid
-23.39-257.25-14.88-508.22
Net Debt Issued (Repaid)
189.52-147.62193.48-248.11
Issuance of Common Stock
-3,308-1,000
Repurchase of Common Stock
-14.68---
Common Dividends Paid
-28.67-35.02-32.1-21.59
Other Financing Activities
--25.41--
Financing Cash Flow
146.173,100161.37730.3
Net Cash Flow
-856.692,84335.13-28.34
Free Cash Flow
-620.75-468.56-323.85-350.52
Free Cash Flow Margin
-2062.65%-38675.98%-68143.75%-894.41%
Free Cash Flow Per Share
-1.69-1.46-1.18-1.27
Cash Income Tax Paid
4-21.69-57.48-17.5
Levered Free Cash Flow
-413.65-267.97-190.87-715.31
Unlevered Free Cash Flow
-395.59-246.1-170.4-695.05
Change in Working Capital
119.3327.89318.9711.57
Source: S&P Global Market Intelligence. Standard template. Financial Sources.